These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26717304)

  • 1. Disease Information in Direct-to-Consumer Prescription Drug Print Ads.
    Aikin KJ; Sullivan HW; Betts KR
    J Health Commun; 2016; 21(2):228-39. PubMed ID: 26717304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall.
    O'Donoghue AC; Williams PA; Sullivan HW; Boudewyns V; Squire C; Willoughby JF
    Soc Sci Med; 2014 Nov; 120():1-11. PubMed ID: 25194471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements.
    Sullivan HW; O'Donoghue AC; Lynch M; Johnson M; Davis C; Rupert DJ
    Med Decis Making; 2019 Nov; 39(8):975-985. PubMed ID: 31583947
    [No Abstract]   [Full Text] [Related]  

  • 4. Communicating efficacy information based on composite scores in direct-to-consumer prescription drug advertising.
    Williams PA; O'Donoghue AC; Sullivan HW; Willoughby JF; Squire C; Parvanta S; Betts KR
    Patient Educ Couns; 2016 Apr; 99(4):583-590. PubMed ID: 26589655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consumers' Understanding of FDA Approval Requirements and Composite Scores in Direct-to-Consumer Prescription Drug Print Ads.
    O'Donoghue AC; Sullivan HW; Williams PA; Squire C; Betts KR; Fitts Willoughby J; Parvanta S
    J Health Commun; 2016 Aug; 21(8):927-34. PubMed ID: 27414000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presenting efficacy information in direct-to-consumer prescription drug advertisements.
    O'Donoghue AC; Sullivan HW; Aikin KJ; Chowdhury D; Moultrie RR; Rupert DJ
    Patient Educ Couns; 2014 May; 95(2):271-80. PubMed ID: 24581929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.
    Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK
    Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual presentations of efficacy data in direct-to-consumer prescription drug print and television advertisements: A randomized study.
    Sullivan HW; O'Donoghue AC; Aikin KJ; Chowdhury D; Moultrie RR; Rupert DJ
    Patient Educ Couns; 2016 May; 99(5):790-9. PubMed ID: 26749356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites.
    Sullivan HW; O'Donoghue AC; Rupert DJ; Willoughby JF; Aikin KJ
    J Health Commun; 2017 Feb; 22(2):171-181. PubMed ID: 28129069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consumer friendly or reader hostile? An evaluation of the readability of DTC print ads.
    Sheehan K
    Health Mark Q; 2008; 23(4):1-16. PubMed ID: 19042509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized study of placebo and framing information in direct-to-consumer print advertisements for prescription drugs.
    O'Donoghue AC; Sullivan HW; Aikin KJ
    Ann Behav Med; 2014 Dec; 48(3):311-22. PubMed ID: 24682975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis.
    Adams C
    J Med Internet Res; 2016 Feb; 18(2):e33. PubMed ID: 26892749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of involvement and ad type on attitudes toward direct-to-consumer advertising of prescription drugs.
    Limbu Y; Torres IM
    J Health Hum Serv Adm; 2009; 32(1):107-38. PubMed ID: 19558035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines.
    Klara K; Kim J; Ross JS
    J Gen Intern Med; 2018 May; 33(5):651-658. PubMed ID: 29484575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asking a doctor versus referring to the Internet: A comparison study on consumers' reactions to DTC (direct-to-consumer) prescription drug advertising.
    Jiang P
    Health Mark Q; 2018; 35(3):209-226. PubMed ID: 30551729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing the educational value of direct-to-consumer advertising of prescription drugs.
    Hwang MJ; Young HN
    J Am Pharm Assoc (2003); 2017; 57(5):571-578. PubMed ID: 28676435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consumer confusion between prescription drug precautions and side effects.
    Amoozegar JB; Rupert DJ; Sullivan HW; O'Donoghue AC
    Patient Educ Couns; 2017 Jun; 100(6):1111-1119. PubMed ID: 28069321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consumer tradeoff of advertising claim versus efficacy information in direct-to-consumer prescription drug ads.
    Aikin KJ; Betts KR; Ziemer KS; Keisler A
    Res Social Adm Pharm; 2019 Dec; 15(12):1484-1488. PubMed ID: 30846370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consumer perceptions of prescription and over-the-counter drug advertisements with promotional offers.
    Aikin KJ; Sullivan HW; O'Donoghue AC; Betts KR
    Health Mark Q; 2016; 33(4):291-306. PubMed ID: 27841741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serious and actionable risks, plus disclosure: Investigating an alternative approach for presenting risk information in prescription drug television advertisements.
    Betts KR; Boudewyns V; Aikin KJ; Squire C; Dolina S; Hayes JJ; Southwell BG
    Res Social Adm Pharm; 2018 Oct; 14(10):951-963. PubMed ID: 28844621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.